𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy

✍ Scribed by Marie-Claire Malinge; Francois Xavier Mahon; Marie Hélène Delfau; Laurence Daheron; Alain Kitzis; François Guilhot; Joseph Tanzer; Bernard Grandchamp


Book ID
114712916
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
601 KB
Volume
82
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Absence of the hybrid bcr-abl mRNA in Ph
✍ Toshiyuki Yamada; Tsuneyuki Oikawa; Noboru Kuzumaki; Nobuo Takagi; Motomichi Sas 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 1015 KB

The expression of c-abl, c-sis, c-myc and N-ras oncogenes was examined in 2 lymphoblastoid cell lines, one with Ph1 (PB-1049) and the other without Ph1 (LN-1049), both established from a patient with chronic myelogenous leukemia (CML), and in a Ph1-positive cell line (PB-1049-T) derived from a tumor

Practical advice for determining the rol
✍ Elias Jabbour; Susan Branford; Giuseppe Saglio; Dan Jones; Jorge E. Cortes; Hago 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 1 views

## Abstract Data demonstrating the superiority of nilotinib over imatinib in the frontline treatment of chronic myeloid leukemia (CML) and ongoing studies with dasatinib and bosutinib are rapidly changing the treatment landscape for CML. In this review, the authors discuss currently available thera